Literature DB >> 27279025

Adult vaccination against tetanus and diphtheria: the European perspective.

B Weinberger1.   

Abstract

Besides immunizations against influenza, Streptococcus pneumoniae and herpes zoster, which are recommended specifically for elderly people, regular booster vaccinations against tetanus, diphtheria and in some cases pertussis and polio are recommended in many European countries for adults, including elderly people. Vaccination recommendations for adults differ greatly between individual countries and coverage data is scarce. Tetanus-specific antibody concentrations are generally higher than diphtheria-specific antibodies, and a substantial proportion of adults, and particularly of elderly people, do not have protective antibody concentrations against diphtheria. Antibody levels increase upon booster vaccination in all age groups, but diphtheria-specific antibody concentrations remain below protective levels in some older individuals, even immediately after vaccination and long-term protection is frequently not achieved. Future vaccination strategies should therefore include regular and well-documented booster shots, e.g. against tetanus and diphtheria, throughout life.
© 2016 British Society for Immunology.

Entities:  

Keywords:  adult vaccination; coverage; diphtheria; elderly people; tetanus

Mesh:

Substances:

Year:  2016        PMID: 27279025      PMCID: PMC5167047          DOI: 10.1111/cei.12822

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  34 in total

1.  Diphtheria antibody levels in the Italian Population.

Authors:  C von Hunolstein; M C Rota; G Alfarone; M L Ricci; S Salmaso
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-06       Impact factor: 3.267

2.  Immunogenicity and reactogenicity of the adult tetanus-diphtheria vaccine. How many doses are necessary?

Authors:  J M Bayas; A Vilella; M J Bertran; J Vidal; J Batalla; M A Asenjo; L L Salleras
Journal:  Epidemiol Infect       Date:  2001-12       Impact factor: 2.451

3.  Variation in adult vaccination policies across Europe: an overview from VENICE network on vaccine recommendations, funding and coverage.

Authors:  Elisabeth E Kanitz; Lauren A Wu; Cristina Giambi; Raymond A Strikas; Daniel Levy-Bruhl; Pawel Stefanoff; Jolita Mereckiene; Eva Appelgren; Fortunato D'Ancona
Journal:  Vaccine       Date:  2012-06-18       Impact factor: 3.641

4.  Duration of humoral immunity to common viral and vaccine antigens.

Authors:  Ian J Amanna; Nichole E Carlson; Mark K Slifka
Journal:  N Engl J Med       Date:  2007-11-08       Impact factor: 91.245

5.  Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax®) followed by two doses of diphtheria, tetanus and poliomyelitis vaccine (Revaxis®) in adults aged ≥ 40 years not receiving a diphtheria- and tetanus-containing vaccination in the last 20 years.

Authors:  Rolf Dominicus; Florence Galtier; Patrick Richard; Martine Baudin
Journal:  Vaccine       Date:  2014-05-19       Impact factor: 3.641

6.  Promoting life course vaccination.

Authors:  Jean-Pierre Michel; Pierre Olivier Lang
Journal:  Rejuvenation Res       Date:  2011-01-05       Impact factor: 4.663

7.  Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix(®)): results of two randomized trials.

Authors:  Wayde M Weston; Leonard R Friedland; Xiangfeng Wu; Barbara Howe
Journal:  Vaccine       Date:  2011-12-31       Impact factor: 3.641

8.  A study of the factors influencing tetanus immunity in Israeli male adults.

Authors:  H Matzkin; S Regev; R Kedem; E Nili
Journal:  J Infect       Date:  1985-07       Impact factor: 6.072

9.  CD4 T cell memory derived from young naive cells functions well into old age, but memory generated from aged naive cells functions poorly.

Authors:  Laura Haynes; Sheri M Eaton; Eve M Burns; Troy D Randall; Susan L Swain
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

Review 10.  Biology of immune responses to vaccines in elderly persons.

Authors:  Birgit Weinberger; Dietmar Herndler-Brandstetter; Angelika Schwanninger; Daniela Weiskopf; Beatrix Grubeck-Loebenstein
Journal:  Clin Infect Dis       Date:  2008-04-01       Impact factor: 9.079

View more
  17 in total

1.  Immunosenescence: the importance of considering age in health and disease.

Authors:  B Weinberger
Journal:  Clin Exp Immunol       Date:  2017-01       Impact factor: 4.330

2.  The recombinant protein combined vaccine based on the fragment C of tetanus toxin and the cross-reacting material 197.

Authors:  Pengdi Chai; Xiuying Pu; Jun Ge; Sulin Ren; Xiaoyu Xia; Amiao Luo; Shiwei Wang; Xiaodong Wang; Jianqiang Li
Journal:  Appl Microbiol Biotechnol       Date:  2021-01-29       Impact factor: 4.813

3.  Evaluation of the Immunization Program in the Federation of Bosnia and Herzegovina - Possible Modalities for Improvement.

Authors:  Fuad Husic; Zaim Jatic; Anes Joguncic; Lutvo Sporisevic
Journal:  Mater Sociomed       Date:  2018-03

Review 4.  Tetanus-diphtheria-acellular pertussis vaccination for adults: an update.

Authors:  Hyo-Jin Lee; Jung-Hyun Choi
Journal:  Clin Exp Vaccine Res       Date:  2017-01-25

5.  Tetanus vaccination status in construction workers: results from an institutional surveillance campaign.

Authors:  Matteo Riccò; Luigi Vezzosi; Carlo Cella; Marco Pecoraro; Giacomo Novembre; Alessandro Moreo; Enrico Maria Ognibeni; Gert Schallenberg; Graziano Maranelli
Journal:  Acta Biomed       Date:  2019-05-23

6.  Immunity status against tetanus in young migrants: a seroprevalence study.

Authors:  Paola Affanni; Maria Eugenia Colucci; Emanuela Capobianco; Maria Teresa Bracchi; Roberta Zoni; Isabella Viani; Luca Caruso; Lucrezia Carlone; Carlo Arcuri; Licia Veronesi
Journal:  Acta Biomed       Date:  2020-04-10

Review 7.  Vaccines for the elderly: current use and future challenges.

Authors:  Birgit Weinberger
Journal:  Immun Ageing       Date:  2018-01-22       Impact factor: 6.400

8.  AuNP-M2e + sCpG vaccination of juvenile mice generates lifelong protective immunity to influenza A virus infection.

Authors:  Lynn Bimler; Amber Y Song; Duy T Le; Ashleigh Murphy Schafer; Silke Paust
Journal:  Immun Ageing       Date:  2019-09-02       Impact factor: 6.400

9.  Pityriasis lichenoides et varioliformis acuta following anti-tetanus and diphtheria adult vaccine.

Authors:  Maira Renata Merlotto; Natália Parente Bicudo; Mariangela Esther Alencar Marques; Silvio Alencar Marques
Journal:  An Bras Dermatol       Date:  2020-02-19       Impact factor: 1.896

10.  Detection of toxin-producing Corynebacterium diphtheriae from throat swabs of diphtheria patients using duplex real-time PCR.

Authors:  Yeva Rosana; Luh Inta Prilandari; Ruhsyahadati Ajisman; Teguh Sarry Hartono; Andi Yasmon
Journal:  Iran J Microbiol       Date:  2020-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.